MustGrow: Organic Disease Control – The Daily Dive

Today on the Daily Dive, we welcome back Colin Bletsky, COO and Director of MustGrow Biologics Corp (CSE: MGRO). Colin joins us today to discuss the company’s recent exclusive agreement with Sumitomo Corporation, the results of its non-exclusive Carnation trials and its economic uses, what distinguishes the company from its competitors, and the sustainability of bio-pesticides.

MustGrow Biologics Corp. is an agriculture biotech company focused on providing natural, science-based biological solutions to replace synthetic chemicals used in high-value crops such as fruit & vegetables. The company uses mustard plant components to deliver high-quality disease, insect pest, and weed control, as well as to apply their technology in the most natural and sustainable way possible to growers, the environment, and customers throughout the world.


FULL DISCLOSURE: MustGrow Biologics Corp is a client of Canacom Group, the parent company of The Deep Dive. The author has been compensated to cover MustGrow Biologics Corp on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

First Phosphate Adds UK Export Finance to Growing Export Credit Lineup With C$220 Million Letter of Interest

Epic Gold Outlines 150,700 Indicated Ounces at 2.26 G/T in Updated Benoist Resource

Related News

MustGrow Sees Executive From Impossible Foods Appointed To Board

MustGrow Biologics (CSE: MGRO) this morning had a major announcement, in that it has appointed...

Monday, December 14, 2020, 07:25:26 AM

MustGrow Biologics Receives $1.5 Million From Exercise Of Warrants

MustGrow Biologics (CSE: MGRO) issued a brief news release this morning, indicating that it has...

Thursday, January 14, 2021, 07:57:13 AM

MustGrow Biologics Demonstrates 100% Control Of Panama Disease In Lab Tests

MustGrow Biologics (CSE: MGRO) has received the results from initial laboratory testing that was conducted...

Tuesday, December 1, 2020, 08:31:08 AM

MustGrow Biologics More Than Triples Financing To $6.9 Million Due To Demand

Demand within the natural biopesticide space from investors appears to be extremely strong. MustGrow Biologics...

Wednesday, September 29, 2021, 08:21:37 AM

MustGrow Biologics To Collaborate With Univar Solutions On Field Trials

MustGrow Biologics (CSE: MGRO) is progressing with field trials for its TerraMG product. The company...

Thursday, April 29, 2021, 08:02:05 AM